Key Highlights
- Catherine Owen Adams appointed CEO, succeeding Steve Davis.
- Adams brings extensive global experience from Bristol Myers Squibb and Johnson & Johnson.
- Acadia advances treatments for Parkinson’s disease psychosis and Rett syndrome.
- Adams aims to accelerate growth, innovation, and new partnerships.
Source: Business Wire
Notable Quotes
- “Catherine is a proven global leader with a distinguished record of accomplishment of driving growth and innovation in the pharmaceutical industry.” — Stephen Biggar, M.D., Ph.D., Chair of the Board of Directors at Acadia Pharmaceuticals
- “I am thrilled to join Acadia at such a pivotal and dynamic time for the company.” — Catherine Owen Adams, CEO at Acadia Pharmaceuticals
- “Catherine’s deep commercial and global expertise is a perfect fit to execute on Acadia’s mission.” — Steve Davis, Former CEO at Acadia Pharmaceuticals
SoHC's Take
Catherine Owen Adams’ appointment marks a significant step forward for Acadia Pharmaceuticals as it enters a critical phase of growth. Her impressive track record at Bristol Myers Squibb and Johnson & Johnson demonstrates her ability to lead large teams, manage expansive portfolios, and drive innovation across multiple therapeutic areas. Acadia is well-positioned to leverage her strategic vision to accelerate development in central nervous system disorders and rare diseases. With its current commercial successes and a promising pipeline, Adams’ leadership will likely bolster Acadia’s long-term impact on patient outcomes.
Heading
Key Highlights Catherine Owen Adams appointed CEO, succeeding Steve Davis. Adams brings extensive global experience from Bristol Myers Squibb and Johnson & Johnson. Acadia advances ...
Key Highlights AffyImmune Therapeutics announces the appointment of Rick Rutter, Ph.D., and Jorge Nieva, M.D., to its Board of Directors. Appointments bolster AffyImmune’s AIC100 CAR T ...
Key Highlights Hims & Hers launches the Service Appreciation Initiative for U.S. military, veterans, teachers, nurses, and first responders. Compounded GLP-1 ...
Key Highlights Matthias Evers, Ph.D., appointed as an independent director at IMIDomics. Dr. Evers brings decades of expertise in life ...
Key Highlights Jill Castilla, President & CEO of Citizens Bank of Edmond, joins CorriXR’s Board of Directors. Visionary leader in finance and ...
Key Highlights Komodo Health unveils two new AI-powered products: MapAI™ and MapExplorer™. MapAI uses generative AI to provide rapid, contextualized healthcare insights. MapExplorer offers a no-code ...